US 8334313
Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
granted A61KA61K31/17A61K31/4166
Quick answer
US patent 8334313 (Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/17, A61K31/4166, A61K31/4172, A61K31/4196